100
Participants
Start Date
January 31, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
January 31, 2027
Anti-Staphylococcus aureus Bacteriophages (PP1493 and PP1815) intra-articular injection with 0.9% NaCl solution
Three intra-articular injections during and/or following DAIR procedure
0.9% NaCl solution
Three intra-articular injections during and/or following DAIR procedure
Lead Sponsor
Phaxiam Therapeutics
INDUSTRY